口服抗凝药物治疗管理路径专家共识  

Expert consensus on the medication therapy management pathway of oral anticoagulant drugs

作　　者：《口服抗凝药物治疗管理路径专家共识》编写组 林阳 彭文星[2] Writing committee of expert consensus on the medication therapy management Pathway of Oral anticoagulant drugs

机构地区：[1]不详 [2]首都医科大学附属北京安贞医院

出　　处：《临床药物治疗杂志》2024年第9期1-23,共23页Clinical Medication Journal

基　　金：国家重点研发计划精准医学研究重点专项(2017YFC0908801)。

摘　　要：为更好地规范和优化口服抗凝药物的治疗管理,提高患者的治疗效果和生活质量,由首都医科大学附属北京安贞医院牵头,邀请了全国31家医疗机构的药学和医学专家共同制订了《口服抗凝药物治疗管理路径专家共识》。本共识紧密围绕口服抗凝药物治疗管理的全过程进行阐述,包括信息收集、适应证与禁忌证的评估、血栓和出血风险评估、药物选择与剂量调整、计划实施及后续跟踪随访等,以期为规范管理服用口服抗凝药物的患者提供参考。To enhance the standardization and optimization of therapeutic management for oral anticoagulant drugs,ultimately improving patients'treatment outcomes and quality of life,Beijing Anzhen Hospital,affiliated with Capital Medical University,spearheaded an initiative by inviting pharmaceutical and medical experts from 31 medical institutions nationwide to jointly formulate the"Expert consensus on the medication therapy management pathway of oral anticoagulant drugs".This consensus comprehensively covers the entire process of managing oral anticoagulant therapy,including information collection,evaluation of indications and contraindications,assessment of thrombosis and bleeding risks,drug selection and dosage adjustment,plan implementation,as well as follow-up,with the aim of providing a reference for managing patients undergoing oral anticoagulant therapy.

关 键 词：共识 口服抗凝药物 药物治疗管理 路径 

分 类 号：R973.2[医药卫生—药品]